-
Publication / Robin Teever, Zanda Frišfelde, Radvilė Kvederaitė, Karin Madisson, Toomas Prangli, Piret Jesse, Eva Berlaus, Nauris Grigals, Algirdas Pekšys, Mantas Petkevičius, Evaldas Dūdonis
Welcome to our comprehensive guide on doing business in Estonia, Latvia, and Lithuania. This document is designed to provide potential investors with an insightful overview of the most relevant commercial conditions in these dynamic Baltic countries. Whether you are considering expanding your business operations, setting up a new venture, or simply exploring opportunities in this […]
-
The discussion surrounding the lack of funding in Estonian healthcare and its deterioration is intensifying, with potential solutions being cautiously presented. We are partnering with AstraZeneca and the American Chamber of Commerce (AmCham) to find new, cross-sector solutions to Estonian healthcare funding challenges. Through our new healthcare platform, we are specifically looking for ideas that […]
-
The limitation period is among the institutions of criminal law for which correct understanding and application is crucial to the final outcome of a case. On the one hand, errors can lead to significant prejudice to the rights of persons entitled to a defence. On the other hand, errors may also create conditions enabling criminal […]
-
We successfully represented the Rakvere city government in a dispute with Virumaa Kompetentsikeskus (Virumaa Competence Centre). The bankruptcy trustee of Virumaa Kompetentsikeskus initiated an action against the Rakvere city government, challenging the validity of certain agreements related to the right of superficies and establishment of usufruct. The bankruptcy trustee sought for the court to annul […]
-
We successfully represented Estonian leading fencer Sten Priinits in appeal proceedings contesting his competition ban. A first in Estonia The Estonian Center for Integrity in Sports (ESTCIS) disciplinary committee issued a decision sanctioning the athlete with an 18-month ineligibility period due to alleged whereabouts failures. Allegedly, Priinits was unavailable for three tests within 12 months. […]
